Abstract
BackgroundEnzyme replacement therapy (ERT) with alglucosidase alfa is the treatment for patients with Pompe disease, a hereditary metabolic myopathy. ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
